12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Company News  |  Other News

AB Science, Skuldtech, Brain and Spine Institute (ICM), French Alternative Energies and Atomic Energy Commission (CEA), French National Institute of Health and

The partners formed the ROMANE consortium, which will receive €8.6 million ($11.3 million) from the Strategic Industrial Innovation (ISI) program of Bpifrance (formerly OSEO), the French innovation funding agency, to develop AB Science's masitinib to treat Alzheimer's disease. AB Science will lead the consortium and will receive €5.9 million ($7.8 million) in...

Read the full 239 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >